Douglass Wu

3.6k total citations · 2 hit papers
18 papers, 3.0k citations indexed

About

Douglass Wu is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Douglass Wu has authored 18 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Douglass Wu's work include Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (4 papers). Douglass Wu is often cited by papers focused on Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (4 papers). Douglass Wu collaborates with scholars based in United States, Taiwan and Japan. Douglass Wu's co-authors include Chi‐Huey Wong, Moriya Tsuji, Masakazu Fujio, David D. Ho, Yuki Kinjo, Mitchell Kronenberg, Michael A. Poles, Guo‐wen Xing, Kazuyoshi Kawahara and Gisen Kim and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Douglass Wu

18 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recognition of bacterial glycosphingolipids by natural killer T cells

2005 742 citations Yuki Kinjo, Douglass Wu et al. Nature profile →
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria

2006 496 citations Yuki Kinjo, Emmanuel Tupin et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglass Wu United States	18	2.2k	592	370	332	284	18	3.0k
Paul Horrocks United Kingdom	30	781 0.4×	955 1.6×	283 0.8×	225 0.7×	139 0.5×	68	2.8k
Kim C. Williamson United States	34	1.6k 0.7×	1.3k 2.1×	297 0.8×	288 0.9×	73 0.3×	81	4.0k
Fernando Rock United States	15	1.2k 0.5×	772 1.3×	161 0.4×	207 0.6×	318 1.1×	19	2.5k
Alexandre Morrot Brazil	33	1.5k 0.7×	863 1.5×	215 0.6×	496 1.5×	176 0.6×	124	3.6k
Jennifer K. Thompson Australia	29	1.1k 0.5×	808 1.4×	533 1.4×	298 0.9×	43 0.2×	52	3.6k
Chrislaine Withers‐Martinez United Kingdom	29	849 0.4×	900 1.5×	223 0.6×	135 0.4×	108 0.4×	53	3.0k
Jean‐François Franetich France	31	784 0.4×	664 1.1×	345 0.9×	192 0.6×	141 0.5×	69	2.9k
Tania F. de Koning‐Ward Australia	35	1.6k 0.7×	1.2k 2.0×	428 1.2×	264 0.8×	40 0.1×	94	4.5k
Thierry Fusaı̈ France	31	507 0.2×	397 0.7×	218 0.6×	330 1.0×	144 0.5×	75	2.4k
Robert T. Sarisky United States	33	811 0.4×	645 1.1×	446 1.2×	561 1.7×	137 0.5×	65	3.0k

Countries citing papers authored by Douglass Wu

Since Specialization

Citations

This map shows the geographic impact of Douglass Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglass Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglass Wu more than expected).

Fields of papers citing papers by Douglass Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglass Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglass Wu. The network helps show where Douglass Wu may publish in the future.

Co-authorship network of co-authors of Douglass Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Douglass Wu. A scholar is included among the top collaborators of Douglass Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglass Wu. Douglass Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Li, Xiangming, Akira Kawamura, Chasity D. Andrews, et al.. (2015). Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node–Resident Dendritic Cells for a Robust Adjuvant Effect. The Journal of Immunology. 195(6). 2710–2721. 17 indexed citations

Padte, Neal N., Chasity D. Andrews, Brooke Grasperge, et al.. (2013). A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates. PLoS ONE. 8(10). e78407–e78407. 37 indexed citations

Li, Xiangming, Masakazu Fujio, Masakazu Imamura, et al.. (2010). Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proceedings of the National Academy of Sciences. 107(29). 13010–13015. 150 indexed citations

Schiefner, A., Masakazu Fujio, Douglass Wu, Chi‐Huey Wong, & Ian A. Wilson. (2009). Structural Evaluation of Potent NKT Cell Agonists: Implications for Design of Novel Stimulatory Ligands. Journal of Molecular Biology. 394(1). 71–82. 38 indexed citations

Kinjo, Yuki, Bo Pei, Simone Bufali, et al.. (2008). Natural Sphingomonas Glycolipids Vary Greatly in Their Ability to Activate Natural Killer T Cells. Chemistry & Biology. 15(7). 654–664. 48 indexed citations

Liang, Pi‐Hui, Masakazu Imamura, Xiangming Li, et al.. (2008). Quantitative Microarray Analysis of Intact Glycolipid−CD1d Interaction and Correlation with Cell-Based Cytokine Production. Journal of the American Chemical Society. 130(37). 12348–12354. 50 indexed citations

Chang, Ya‐Jen, Jingrong Huang, Yi-Chien Tsai, et al.. (2007). Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proceedings of the National Academy of Sciences. 104(25). 10299–10304. 139 indexed citations

Wu, Douglass, Masakazu Fujio, & Chi‐Huey Wong. (2007). Glycolipids as immunostimulating agents. Bioorganic & Medicinal Chemistry. 16(3). 1073–1083. 103 indexed citations

Brigl, Manfred, Peter van den Elzen, Xiuxu Chen, et al.. (2006). Conserved and Heterogeneous Lipid Antigen Specificities of CD1d-Restricted NKT Cell Receptors. The Journal of Immunology. 176(6). 3625–3634. 83 indexed citations

10.

Kinjo, Yuki, Emmanuel Tupin, Douglass Wu, et al.. (2006). Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nature Immunology. 7(9). 978–986. 496 indexed citations breakdown →

11.

Fujio, Masakazu, Douglass Wu, Raquel García‐Navarro, et al.. (2006). Structure-Based Discovery of Glycolipids for CD1d-Mediated NKT Cell Activation: Tuning the Adjuvant versus Immunosuppression Activity. Journal of the American Chemical Society. 128(28). 9022–9023. 102 indexed citations

12.

Wu, Douglass, Dirk M. Zajonc, Masakazu Fujio, et al.. (2006). Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proceedings of the National Academy of Sciences. 103(11). 3972–3977. 114 indexed citations

13.

Xing, Guo‐wen, Douglass Wu, Michael A. Poles, et al.. (2005). Synthesis and human NKT cell stimulating properties of 3-O-sulfo-α/β-galactosylceramides. Bioorganic & Medicinal Chemistry. 13(8). 2907–2916. 43 indexed citations

14.

Zajonc, Dirk M., Igor Maricic, Douglass Wu, et al.. (2005). Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. The Journal of Experimental Medicine. 202(11). 1517–1526. 162 indexed citations

15.

Kinjo, Yuki, Douglass Wu, Gisen Kim, et al.. (2005). Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 434(7032). 520–525. 742 indexed citations breakdown →

16.

Wu, Douglass, Guo‐wen Xing, Michael A. Poles, et al.. (2005). Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proceedings of the National Academy of Sciences. 102(5). 1351–1356. 189 indexed citations

17.

Wu, Chung‐Yi, Jia-Tsrong Jan, Chih‐Jung Kuo, et al.. (2004). Small molecules targeting severe acute respiratory syndrome human coronavirus. Proceedings of the National Academy of Sciences. 101(27). 10012–10017. 406 indexed citations

18.

Lee, Lac V., Fu‐Sen Liang, Douglass Wu, et al.. (2004). Inhibition of the Proteolytic Activity of Anthrax Lethal Factor by Aminoglycosides. Journal of the American Chemical Society. 126(15). 4774–4775. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact